OVCON-50 Drug Patent Profile
When do Ovcon-50 patents expire, and when can generic versions of Ovcon-50 launch?
Ovcon-50 is a drug marketed by Warner Chilcott and Warner Chilcott Llc and is included in two NDAs.
The generic ingredient in OVCON-50 is ethinyl estradiol; norethindrone. There is one drug master file entry for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for OVCON-50?
- What are the global sales for OVCON-50?
- What is Average Wholesale Price for OVCON-50?
Summary for OVCON-50
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 6 |
| Patent Applications: | 223 |
| DailyMed Link: | OVCON-50 at DailyMed |
US Patents and Regulatory Information for OVCON-50
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Warner Chilcott | OVCON-50 | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 018128-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Warner Chilcott Llc | OVCON-50 | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 017576-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
